Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UR-1505 topical ointment in mild to moderate atopic dermatitis
2007-002550-27Phase 2Active
- Sponsor
- Palau Pharma
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of UR-1505 in atopic dermatitis (AD) (5 arms), sponsored by Palau Pharma. Primary endpoint: Investigator Global Assessment (IGA) score at day 28. Started Jun 2007; status: active.
02
Drugs
UR-1505
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2007-002550-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002550-27.